PIVOTAL BIOVENTURE PARTNERS
Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
PIVOTAL BIOVENTURE PARTNERS
Social Links:
Industry:
Biotechnology Venture Capital
Founded:
2017-01-04
Status:
Active
Contact:
415-697-1002
Email Addresses:
[email protected]
Technology used in webpage:
SPF DMARC Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Facebook Sharer GoDaddy DNS COVID-19 WP Engine Apple ICloud Mail
Similar Organizations
Apollo Health Ventures
Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.
Formic Ventures
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups
Bionova Capital
Bionova Capital is a healthcare-focused venture capital firm, investing in early-stage startups across Europe.
Iris Family Office
The Iris Family Office is San Francisco based and invests in multiple asset classes, but primarily in late stage tech companies.
K2VC
K2VC is a venture capital firm investing in early stage technology startups.
Scale-Up Venture Capital
Scale-Up VC is a venture capital firm that makes investments in late and growth stage technology companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-10-31 | Evommune | Pivotal bioVenture Partners investment in Series C - Evommune | 115 M USD |
| 2024-05-07 | Zenas BioPharma | Pivotal bioVenture Partners investment in Series C - Zenas BioPharma | 200 M USD |
| 2024-02-13 | BioAge Labs | Pivotal bioVenture Partners investment in Series D - BioAge Labs | 170 M USD |
| 2023-09-27 | Avalyn Pharma | Pivotal bioVenture Partners investment in Series C - Avalyn Pharma | 175 M USD |
| 2023-04-26 | Evommune | Pivotal bioVenture Partners investment in Series B - Evommune | 50 M USD |
| 2023-03-08 | Heranova Lifesciences | Pivotal bioVenture Partners investment in Seed Round - Heranova Lifesciences | 10 M USD |
| 2023-03-03 | Oculis | Pivotal bioVenture Partners investment in Post-IPO Equity - Oculis | 91 M USD |
| 2022-11-07 | Zenas BioPharma | Pivotal bioVenture Partners investment in Series B - Zenas BioPharma | 118 M USD |
| 2022-02-23 | Plexium | Pivotal bioVenture Partners investment in Series B - Plexium | 102 M USD |
| 2022-02-10 | Arkuda Therapeutics | Pivotal bioVenture Partners investment in Series B - Arkuda Therapeutics | 64 M USD |
More informations about "Pivotal bioVenture Partners"
Pivotal bioVenture Partners - Crunchbase
Pivotal bioVenture Partners may be growing as it has recently closed a significant fund, which is indicative of increased financial resources available for investment. The firm unveiled a $389 million fund, which brings its total commitments to …See details»
Pivotal Life Sciences | Venture Capital | Public Equity
Pivotal bioVenture Partners China. We specialize in venture building in the life sciences industry, partnering with innovative healthcare companies in the Greater China region. Learn More. …See details»
Pivotal Life Sciences Announces the Closing of $389M for Pivotal ...
Dec 18, 2023 Pivotal bioVenture Partners operates under the broader Pivotal Life Sciences group, a life sciences asset management platform focused on investing in therapeutic …See details»
Pivotal Life Sciences Announces the Closing of $389M for Pivotal ...
SAN FRANCISCO, December 18, 2023--Pivotal Life Sciences (the "Firm"), a global investment firm dedicated to investing in companies involved in healthcare innovation seeking to improve …See details»
Pivotal Bio | Life Sciences Venture Capital Firm in China
Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences, is a venture capital firm specializing in venture building in the life sciences industry. Read More » Read More » Our TeamSee details»
In Second Fund, Pivotal Raises $389M to Create and Support ...
Dec 18, 2023 Pictured: San Francisco’s Golden Gate Bridge/ iStock, bloodua San Francisco–based venture capital firm Pivotal bioVenture Partners announced Monday it has …See details»
Pivotal bioVenture Partners - Investments, Portfolio & Company Exits
Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Pivotal Bio | Team - Vincent Cheung
Vincent is the Chairman of Nan Fung Life Sciences. He founded Pivotal bioVenture Partners in 2017 and Pivotal bioVenture Partners China in 2018. Vincent is also the Managing Director …See details»
Pivotal bioVenture Partners unveils $389M fund
Dec 18, 2023 Pivotal bioVenture Partners has closed its second fund of $389 million, money that will go toward North American and European companies working to develop new therapeutics. | Pivotal bioVenture ...See details»
Pivotal bioVenture raises the stakes in biotech and …
Dec 18, 2023 Pivotal bioVenture raises the stakes in biotech and pharmaceutical support. The latest $389m pledge follows an initial investment of $300m in 2017 that was raised to fund early-stage life-science startups. ...See details»
Pivotal bioVenture Partners closes $300M early biotech fund
Mar 16, 2017 The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised its first fund, totaling $300 million, as it looks to help early-stage life science startups get off the …See details»
Pivotal bioVenture Partners Closes Inaugural $300 Million Life …
Mar 16, 2017 Media and Investors: Pivotal bioVenture Partners Tracy Saxton, 415-697-1002 [email protected] or Pure Communications Julie Normart, 415-946-1087 …See details»
Pivotal bioVenture Partners Fund II: Performance - PitchBook
Dec 31, 2021 Pivotal bioVenture Partners Fund II is a 2021 vintage venture capital fund managed by Pivotal bioVenture Partners and Pivotal Life Sciences. The fund is located in San …See details»
Pivotal Life Sciences Announces the Closing of $389M for Pivotal ...
The Fund II closing brings Pivotal bioVenture Partners’ total aggregate capital commitments to $689 million. Pivotal bioVenture Partners invests in companies at all stages from seed stage to …See details»
VC firm Pivotal closes second $389M therapeutics fund to create ...
Dec 18, 2023 Rob Hopfner, Pivotal bioVenture Partners managing general partner (Credit: Pivotal Life Sciences) December 18, 2023 07:00 AM EST Updated December 19, 06:29 AM. …See details»
Pivotal Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pivotal Therapeutics Inc of Woodbridge, ON. Get the latest business insights from Dun & Bradstreet.See details»
Pivotal Therapeutics - Crunchbase Company Profile & Funding
Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. Pivotal developed its lead …See details»
Pivotal Therapeutics Inc. (PVTTF) - Yahoo Finance Canada
See the company profile for Pivotal Therapeutics Inc. (PVTTF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Pivotal Therapeutics Company Profile - Office Locations ... - Craft
May 24, 2024 Partners. Resources. Company. Toggle menu. ... Stock Price. $0. 2024-05-24. Market Capitalization. $172.4 K. 2024-05-24. Pivotal Therapeutics Summary. Company …See details»